A survey of Korean medicine doctors’ clinical practice patterns for autism spectrum disorder: preliminary research for clinical practice guidelines

Autism spectrum disorder (ASD) is a lifelong, neurodevelopmental disorder characterized by deficits in social interaction and communication, and restricted and repetitive patterns of behavior, interests, and activities [1]. Approximately 1 in 68 children has been identified with ASD in the United States, with an average prevalence of 1–2% in Asia, Europe, and North America [2]. The prevalence of ASD in a total population sample of South Korean children aged 7–12 years was estimated to be 2.64% [3]. There is no known widely accepted treatment method, but interventions may improve symptoms. Treatment modalities for ASD are categorized as behavioral and educational interventions, psychopharmacologic interventions, and complementary and alternative medicine (CAM) [4].

Korean medicine (KM) has developed similarly to East Asian traditional medicine, such as traditional Chinese medicine and Oriental medicine in Japan [5]. In parallel with the medical system in South Korea, Korean medicine doctors (KMDs) are licensed to independently practice all main curative methods of Korean medical treatments, unlike medical doctors (MDs) who utilize conventional medicine [6, 7]. The main KM therapeutic methods include acupuncture, moxibustion, cupping, herbal medicines, and manual therapies [6]. The KM training system is similar to that of conventional medicine, with 6 years of undergraduate education and a national licensing examination [8]. In 2013, there were 21,355 KMDs in South Korea. The percentage of KMDs among total doctors (including KMDs, MDs, and dental doctors) is 13.5% [9]. The KM specialist training system was introduced in 1999 by the Ministry of Health and Welfare, with reference to the conventional medicine specialist system. After getting a KM license, KMDs choose to train in a designated KM hospital for 4 years (1-year internship and 3-year residence course) and can obtain specialist certification [6]. KMDs with specialist license accounted for 14.3% of all KMDs by 2015 [10]. The types of specialty subjects include internal medicine, acupuncture and moxibustion, rehabilitation medicine, pediatrics, gynecology, ophthalmology, otorhinolaryngology, dermatology, neuropsychiatry, and Sasang constitutional medicine. In 2012, the medical expenses for KM were 4 billion USD, and the proportion of National Health Expenditure was 4.5% [11].

Clinical practice guidelines (CPGs) assist healthcare providers and patients in making treatment decisions [12]. A CPG for ASD has not yet been established in both KM and conventional medicine fields in Korea. KMDs use herbal medicine and acupuncture to treat patients with ASD [13, 14]. However, KM treatment for ASD is not standardized, since KMDs use different KM syndrome differentiations and therapeutic methods. KMDs have difficulty obtaining conclusive evidence for practice, and thus, there is a need to develop evidence-based CPGs for ASD that follow a systematic methodology. The CPGs are required to reflect the current state of KM treatment. The aim of the current study was to investigate ASD clinical practice patterns of KMDs through a questionnaire survey.

In the current study, 61.1% of respondents were men, 48.1% were aged 30–39 years, and 44.4% had 10–19 years of experience as a KMD. A total 83.3% were specialists certified by the Korean Ministry of Health and Welfare. Among them, 60% were certified by the Society of Korean Medicine Neuropsychiatry, and 40% were licensed by the Society of Korean Medicine Pediatrics. For most KMDs (83.3%), the proportion of patients with ASD among the total outpatients was less than 5%. The main age group of patients treated by respondents was aged 6–10 years (47.7%) (Table 1).

KM syndrome differentiation was generally used (88.9%) in the diagnostic process. The most frequently answered KM syndrome differentiation theory was ‘Organ system, Qi, Blood, Yin, Yang, Fluid, and Humor diagnosis’ (68.2%), followed by ‘Four-constitutional medicine diagnosis’ (18.2%), and ‘Six meridian diagnosis’ (10.6%). Of the titles of syndrome differentiation on ASD, ‘Heart deficiency with timidity (心虛膽怯)’ (12.8%) was most frequently used, followed by ‘Liver qi depression (肝鬱氣結)’ (10%), and ‘Phlegm confounding the orifices of the heart (痰迷心竅)’ (10%). ASD was commonly diagnosed based on the fourth edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-IV; 26.7%) and DSM-5 (23.8%) (Table 2).

The most frequently prescribed KM treatment for ASD was herbal medicine (27.3%), followed by body acupuncture (17.6%), scalp acupuncture (10.7%), and moxibustion (6.4%). The main targets of KM treatment were to alleviate emotional problems (21.7%), improve physical health (18.1%), or improve cognitive ability (16.7%). The most commonly used herbal medicines were Yukmijihwang-tang (12.4%), Ondam-tang (11.2%), and Gwibi-tang (7.7%). Among the single herbs, Acori Graminei Rhizoma (9.5%), Polygalae Radix (8.5%), and Poria (7%) were frequently used. KMDs mainly prescribed compound herbal decoction (55.7%) among the various types of herbal medicine. Herbal medicine for ASD was commonly prescribed to be taken twice a day (61.8%), with a treatment duration of 3–6 months (40.4%), 1–3 months (21.1%), or 6 months to 1 year (21.1%). Regarding acupuncture treatment, GV20 (15.4%), LI4 (11.7%), and Ex-HN1 (Sasinchong, Sishencong) points (8.1%) were the most widely used acupoints. The most commonly applied pharmacopuncture was Hominis Placenta (10.6%) (Table 3). KMDs mainly performed body acupuncture twice (43.8%) or once (37.5%) a week. Scalp acupuncture was also conducted twice (50%) or once (34.6%) a week. The most predominant duration of body acupuncture treatment was 3–6 months (36.6%) or more than 1 year (31.7%). Scalp acupuncture was mainly applied for more than 1 year (34.8%) or 3–6 months (26.1%).

ASD is a lifetime disease and causes a heavy burden to both families and society. The economic cost for children with ASD in the United States is between 11.5–60.9 billion USD, including healthcare and special education costs, and lost income [20, 21]. No single intervention has been confirmed as being effective in relieving the main symptoms of ASD, which is one reason why families of patients with ASD seek CAM [22, 23]. It was reported that 30–74% of children with ASD used CAM [24‐26]. There are published reports on KM treatment for ASD, including herbal medicine and acupuncture, such as case reports [13, 14, 27] and reviews [28, 29]. However, the status of KM or CAM use on children with ASD has not yet been investigated in Korea. The present research was conducted to report the current state of KM treatment for children with ASD.

The rate of ASD among the outpatients that responded was less than 5%, which might be related to the low prevalence of ASD [2, 3]. In addition, KM may be used infrequently to treat ASD in Korea [30‐32]. Patients with ASD treated by the respondents were predominantly aged 3–5 or 6–10 years, when multiple responses were allowed. This may have relevant to the fact that most children are not diagnosed with ASD until after 4 years of age [2].

Most KMDs answered that they were using KM syndrome differentiation. Syndrome differentiation is a type of diagnostic method that decides the syndrome based on a group of coexistent symptoms and signs [33]. After syndrome differentiation is decided, the KMDs select the treatment method, including herbal medicine and acupuncture. Syndrome differentiation enables KM treatment to fit individual physical features, and signs and symptoms. When KMDs examine a patient and determine a diagnosis, they significantly consider diseases identification (辨病) as well as syndrome differentiation [34]. In the current study, most KMDs replied that they diagnosed ASD based on DSM-IV and DSM-5. Some KMDs did not use diagnostic tools but decided to conduct the diagnosis based on symptoms. For accurate diagnosis and assessment of treatment, it is recommended that standardized diagnostic tools and appropriate evaluation indexes should be used.

The respondents preferred to use herbal medicine, mostly choosing compound herbal decoction when prescribing herbal medicine. When prescribing compound herbal decoction, KMDs can mix several kinds of herbs in varying amounts, and it can be more effective and helpful for patients with different symptoms and constitutional characteristics. The most frequently prescribed herbal medicine was Yukmijihwang-tang. The memory enhancing and learning function of Yukmijihwang-tang has been demonstrated in laboratory studies [35, 36], with published case studies about herbal medicine containing Yukmijihwang-tang for ASD treatment [13, 14]. Clinical studies on the use of Yukmijihwang-tang in pediatric patients, however need to conducted using rigorous methodology.

Patients with ASD have diverse symptoms, with varying degrees of impairment in social and communication function. KMDs mostly targeted the reduction of emotional problems such as anxiety, irritation, and moodiness. Improving physical condition, associated with food intake, digestion, defecation, and sleep, was also an important therapeutic goal. Gastrointestinal symptoms accounted for a high percentage of the CAM used for children with ASD in the United States [37]. To accurately evaluate the overall therapeutic effect, several assessment indicators for various symptoms will be needed.

Our study has some limitations that need to be noted. One of the most general methods of surveying KMDs is to send e-mails containing a web-based questionnaire to all KMDs through the Associations of Korean Medicine. Nevertheless, this approach is known to have low response rates (3.9–11.1%) [38, 39]. Patients chiefly visit a KM clinic to be treated for musculoskeletal disorders, and the frequency of KM treatment of mental disorders is low in Korea [11]. Thus, we postulated that there was a high probability that general KMDs would not respond to the survey. Therefore, we did not target all KMDs, but sent e-mails to all KM psychiatrists and pediatricians through the Society of Korean Medicine Neuropsychiatry and Society of Korean Medicine Pediatrics, and KMDs who were found by internet searching. Thus, this process may have had a selection bias for KMDs who use e-mails or run a website. Therefore, there may have been some KMDs who treat ASD that were excluded from the analysis. In addition, our study does not show the effect of each of interventions on core symptoms of ASD. Future studies would entail researching the efficacy and safety of specific KM treatments for patients with ASD. Further, the standpoint of families on using KM treatment for ASD has not been examined. Thus, a study on caregiver perceptions about the efficacy, expectation and rationale for using KM treatment is warranted.

The questionnaire employed also has several limitations. There were a lot of items to answer and the length of the questionnaire was long. This may account for missing data. When asked about the type of pharmacopuncture used, 18 KMDs stated the type of pharmacopuncture used, 28 people replied that they did not use pharmacopuncture, and 8 KMDs did not answer this question. We excluded missing data and performed a multiple response analysis. Second, the validity of the questionnaire was partially verified. We searched former survey studies [7, 40, 41] on KM treatment, but did not find validated questionnaires. Accordingly, we derived and modified a considerable number of items from several studies. A panel of experts reviewed the questionnaire, but statisticians or methodologists were not included in the panel. Third, we allowed respondents to provide multiple responses to most items because we intended for the survey to reflect the reality that KMDs judge and change the treatment method according to the circumstances. Another reason for allowing plural responses was that KM treatment was not highly standardized for ASD.

This is the first survey report on clinical practice pattern of KM treatment of ASD. The draft of CPG for KM treatment of ASD was completed in June 2017, and preliminary certification by the Guideline Center for Korean Medicine was obtained in September 2017; it is yet to be published. When establishing a CPG for ASD, the research team reflected on the findings of the current study and made recommendations for each diagnosis and treatment method. Based on the survey results, detailed information was also included that can be used when KMDs treat patients with ASD. In the course of the preparation of the CPG, the research team collected and analyzed practice guidelines and literatures on ASD, and systematically reviewed the efficacy and safety of herbal medicine [42] and acupuncture [43]. In addition, a randomized controlled trial using an herbal medicine, which the present study identified as being widely used, has been scheduled for 2018. The future CPG will be used as an evidence-based guideline in KM institutions, helping KMDs make decisions about ASD and improving the quality and reliability of medical treatment.

The present study demonstrated the current status of KMDs’ clinical practice patterns for ASD. KMDs commonly used KM syndrome differentiations when diagnosing patients with ASD patients; the ‘Organ system, Qi, Blood, Yin, Yang, Fluid and Humor diagnosis’ was most frequently used among KM syndrome differentiation theories. In addition, herbal medicine and body acupuncture are the most employed KM interventions. Among herbal medicines, Yukmijihwang-tang was the most frequently prescribed. The data of this survey will serve as the basis for CPGs and future clinical trials on ASD. Standardized and reliable CPGs will enable KMDs and patients make rational clinical decisions.